Founded out of Université catholique de Louvain and Wageningen University research, A-Mansia Biotech hopes to commercialise nutritional supplements for patients at heightened cardio-metabolic risk.

DSM Venturing co-led a $22.5m round for Miach Orthopaedics, which is developing an implant to treat ACL injuries.

Mastercard and American Express backed the online consumer finance provider in a series A round co-led by Dawn Capital and DN Capital.

Fosun RZ Capital has led a series A round for designer clothing e-commerce platform ICY.

Novartis and Astellas Venture Management both invested as the gene therapy developer announced its first external funding.

The healthcare communication platform developer has closed a $40.5m round backed by several health insurers and care providers.

Silverback Therapeutics, which is developing drugs that will only act at the site of disease, has closed a $47.5m round backed by Celgene.

Zalando and Children’s Investment Fund Foundation have added $2.5m to Working Capital's supply chain-focused fund, which now stands at $25.2m.

The Forbes-backed end-to-end healthcare product supplier has raised $88m in series A funding and added a smoking cessation service.

Autonomous vehicle software spinout Oxbotica has secured IP Group, Parkwalk Advisors and Axa XL as investors in its first publicly-disclosed funding round.